Bon Natural Life Limited
BON · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.79 | -0.62 | 0.03 | 16.01 |
| FCF Yield | -6.97% | -0.77% | -1.08% | -0.05% |
| EV / EBITDA | 51.46 | 13.85 | 55.29 | 233.27 |
| Quality | ||||
| ROIC | 1.85% | 12.10% | 15.31% | 15.36% |
| Gross Margin | 29.82% | 29.94% | 31.51% | 27.90% |
| Cash Conversion Ratio | -21.17 | -0.14 | -0.03 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.27% | 5.01% | 17.96% | 15.85% |
| Free Cash Flow Growth | -982.89% | 85.50% | -602.49% | 58.53% |
| Safety | ||||
| Net Debt / EBITDA | 3.14 | 0.57 | 0.55 | 0.23 |
| Interest Coverage | 6.18 | 24.84 | 14.64 | 12.94 |
| Efficiency | ||||
| Inventory Turnover | 10.64 | 1.28 | 11.90 | 3.23 |
| Cash Conversion Cycle | 140.37 | 316.32 | 109.66 | 193.53 |